We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVOL icon
4276
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$74M
$12K ﹤0.01%
485
+474
+4,309% +$12.6K
DXJ icon
4277
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
$12K ﹤0.01%
200
-323
-62% -$20.6K
ESGE icon
4278
iShares ESG Aware MSCI EM ETF
ESGE
$6.87B
$12K ﹤0.01%
+366
New +$12.4K
FEP icon
4279
First Trust Europe AlphaDEX Fund
FEP
$537M
$12K ﹤0.01%
+382
New +$13.6K
FRAF icon
4280
Franklin Financial Services
FRAF
$289M
$12K ﹤0.01%
386
+324
+523% +$10.1K
FXNC icon
4281
First National Corp
FXNC
$289M
$12K ﹤0.01%
+637
New +$12.8K
HAYW icon
4282
Hayward Holdings
HAYW
$3.23B
$12K ﹤0.01%
857
+205
+31% +$3.16K
IKT icon
4283
Inhibikase Therapeutics
IKT
$374M
$12K ﹤0.01%
2,670
+2,404
+904% +$14.2K
KITT icon
4284
Nauticus Robotics
KITT
$6.72M
-1
Closed -$26.1K
KRON
4285
DELISTED
Kronos Bio
KRON
$12K ﹤0.01%
3,308
+719
+28% +$3.26K
KRRO icon
4286
Korro Bio
KRRO
$190M
$12K ﹤0.01%
154
+25
+19% +$1.69K
LAKE icon
4287
Lakeland Industries
LAKE
$118M
$12K ﹤0.01%
755
-1,542
-67% -$26.2K
LOOP icon
4288
Loop Industries
LOOP
$32.2M
$12K ﹤0.01%
+2,981
New +$18.5K
MLP icon
4289
Maui Land & Pineapple Co
MLP
$308M
$12K ﹤0.01%
1,278
+1,052
+465% +$11.4K
DFTX
4290
Definium Therapeutics
DFTX
$5.81B
$12K ﹤0.01%
1,236
+628
+103% +$7.95K
NPK icon
4291
National Presto Industries
NPK
$1B
$12K ﹤0.01%
190
-5,099
-96% -$362K
NTRB icon
4292
Nutriband
NTRB
$39.3M
$12K ﹤0.01%
3,516
+1,233
+54% +$4.49K
OXLC
4293
Oxford Lane Capital
OXLC
$946M
$12K ﹤0.01%
407
+363
+825% +$11.9K
PALI icon
4294
Palisade Bio
PALI
$369M
$12K ﹤0.01%
40
+33
+471% +$15.9K
PBFS icon
4295
Pioneer Bancorp
PBFS
$418M
$12K ﹤0.01%
1,198
-4,258
-78% -$43.1K
PED icon
4296
PEDEVCO
PED
$173M
$12K ﹤0.01%
543
+163
+43% +$4.17K
PVBC
4297
DELISTED
Provident Bancorp
PVBC
$12K ﹤0.01%
789
-1,845
-70% -$28.7K
QRHC icon
4298
Quest Resource Holding
QRHC
$34.4M
$12K ﹤0.01%
3,128
+2,409
+335% +$12.1K
RDW icon
4299
Redwire
RDW
$3.39B
$12K ﹤0.01%
3,840
+880
+30% +$4.24K
LNAI
4300
Lunai Bioworks
LNAI
$9.93M
$12K ﹤0.01%
78
+30
+63% +$13.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.